Drug Trial Radar · NCT03673462
Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
Last checked: Nov 20, 2026Latest source record: Dec 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,797
Actual
Start
Sep 17, 2018
Primary completion
Mar 16, 2023
Study completion Mar 16, 2023
Sponsor
- Lead sponsor
- Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
- Sponsor type
- Industry
- First posted
- Sep 17, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 42 days, up to 89 days
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of this study was to describe the safety profile of Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid (MenACYW) Conjugate Vaccine and Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 (MENVEO®) Conjugate Vaccine when administered concomitantly with routine pediatric vaccines in healthy infants and toddlers.
Conditions
- Healthy Volunteers (Meningococcal Infection)
Interventions
Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine (MenACYW Conjugate vaccine)Biological
Pharmaceutical form: Liquid solution. Route of administration: Intramuscular
Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine (MENVEO®)Biological
Pharmaceutical form: Lyophilized powder combined with liquid components Route of administration: Intramuscular
Diphtheria, Tetanus, Acellular Pertussis, Poliovirus and Haemophilus b VaccineBiological
Pharmaceutical form: Liquid DTaP-IPV to reconstitute lyophilized ActHIB Route of administration: Intramuscular
Pneumococcal 13-valent Conjugate VaccineBiological
Pharmaceutical form: Suspension for injection Route of administration: Intramuscular
Rotavirus VaccineBiological
Pharmaceutical form: Oral solution Route of administration: Oral
Hepatitis B VaccineBiological
Pharmaceutical form: Suspension for injection Route of administration: Intramuscular
Measles, Mumps, and Rubella Virus VaccineBiological
Pharmaceutical form: Lyophilized live virus vaccine Route of administration: Subcutaneous
Varicella Virus VaccineBiological
Pharmaceutical form: Suspension for injection Route of administration: Subcutaneous
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Immediate Unsolicited Systemic Adverse Events (AEs)Time frame: Within 30 minutes post-any vaccination
- Number of Participants With Solicited Injection Site ReactionsTime frame: Within 7 days post any vaccination
- Number of Participants With Solicited Systemic ReactionsTime frame: Within 7 days post-any vaccination
- Number of Participants With Unsolicited Adverse EventsTime frame: Within 30 days post any vaccination
- Number of Participants With Serious Adverse Events (SAEs) and Adverse Event of Special Interest (AESIs)Time frame: From day of first vaccination (i.e., at the age of 2 months) up to 6 months after last vaccination (i.e., up to the age of 18 months)
- Number of Participants With Medically Attended Adverse Event (MAAEs)Time frame: From day of first vaccination (i.e., at the age of 2 months) up to 6 months after last vaccination (i.e., up to the age of 18 months)
Locations
69 sites in 2 countries. Site status is shown where the registry gives one.
Birmingham Pediatric Associates-Site Number:8400049
Birmingham, Alabama
Southeastern Pediatric Associates-Site Number:8400034
Dothan, Alabama
MedPharmics, LLC - Phoenix-Site Number:8400043
Phoenix, Arizona
Northwest Arkansas Pediatric Clinic-Site Number:8400042
Fayetteville, Arkansas
HealthStar Research, LLC-Site Number:8400100
Hot Springs, Arkansas
The Children's Clinic of Jonesboro, PA-Site Number:8400059
Jonesboro, Arkansas
Emmaus Research Center, Inc-Site Number:8400057
Anaheim, California
Advanced Clinical Research - Rancho Paseo-Site Number:8400087
Banning, California
Premier Health Research Center, LLC-Site Number:8400039
Downey, California
Center for Clinical Trials, LLC-Site Number:8400056
Paramount, California
Center for Clinical Trials of San Gabriel-Site Number:8400051
West Covina, California
Center for Clinical Trials of San Gabriel-Site Number:8400099
West Covina, California
Optum Clinical Research-Site Number:8400076
Colorado Springs, Colorado
IMMUNOe Research Centers - Thornton-Site Number:8400022
Thornton, Colorado
Avail Clinical Research, LLC-Site Number:8400055
DeLand, Florida
Advanced Research for Health Improvement-Site Number:8400096
Fort Myers, Florida
Sarkis Clinical Trials-Site Number:8400003
Gainesville, Florida
De Armas Research Center,-Site Number:8400088
Miami, Florida
Healthy Life Research-Site Number:8400075
Miami, Florida
Acevedo Clinical Research Associates-Site Number:8400032
Miami, Florida
Crystal Biomedical Research-Site Number:8400018
Miami Lakes, Florida
Advanced Research for Health Improvement-Site Number:8400005
Naples, Florida
Meridian Clinical Research-Site Number:8400114
Macon, Georgia
MOC Research-Site Number:8400095
Mishawaka, Indiana
Kentucky Pediatics / Adult Research-Site Number:8400044
Bardstown, Kentucky
University of Louisville-Site Number:8400082
Louisville, Kentucky
Brownsboro Park Pediatrics-Site Number:8400040
Louisville, Kentucky
All Children Pediatrics-Site Number:8400069
Louisville, Kentucky
MedPharmics-Site Number:8400048
Metairie, Louisiana
Pediatric Associates of Fall River-Site Number:8400103
Fall River, Massachusetts
MedPharmics Biloxi-Site Number:8400052
Biloxi, Mississippi
Craig Spiegel, MD-Site Number:8400067
Bridgeton, Missouri
Center for Pharmaceutical Research-Site Number:8400080
Kansas City, Missouri
Midwest Childrens Health Research Institute-Site Number:8400060
Lincoln, Nebraska
Legacy Pediatrics-Site Number:8400004
Rochester, New York
Medication Management-Site Number:8400072
Greensboro, North Carolina
Ford, Simpson, Lively & Rice Pediatrics-Site Number:8400021
Winston-Salem, North Carolina
Ohio Pediatric Research-Site Number:8400064
Dayton, Ohio
PriMed Clinical Research-Site Number:8400033
Dayton, Ohio
Senders Pediatrics-Site Number:8400061
South Euclid, Ohio
Showing 40 of 69 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.